TARGETED TREATMENT OF PAPILLARY CRANIOPHARYNGIOMAS HARBORING BRAFV600E MUTATIONS

被引：0
|
作者：
Juratli, Tareq [1 ]
Jones, Pamela [1 ]
Wang, Nancy [1 ]
Subramanian, Megha [1 ]
Aylwin, Simon [2 ]
Odia, Yazmin [3 ]
Rostami, Elham [4 ]
Gudjonsson, Olafur [4 ]
Shaw, Brian [1 ]
Cahill, Daniel [1 ]
Uhm, Joon [5 ]
Galanis, Evanthia [5 ]
Barker, Fred [1 ]
Santagata, Sandro [6 ]
Brastianos, Priscilla [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Kings Coll Hosp London, London, England
[3] Miami Canc Inst, BHSF, Miami, FL USA
[4] Uppsala Univ, Dept Neurosci, Uppsala, Sweden
[5] Mayo Clin, Rochester, MN USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RARE-04
引用
下载
收藏
页码：222 / 222
页数：1
相关论文
共 50 条
  • [1] Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
    Juratli, Tareq A.
    Jones, Pamela S.
    Wang, Nancy
    Subramanian, Megha
    Aylwin, Simon J. B.
    Odia, Yazmin
    Rostami, Elham
    Gudjonsson, Olafur
    Shaw, Brian L.
    Cahill, Daniel P.
    Galanis, Evanthia
    Barker, Fred G., II
    Santagata, Sandro
    Brastianos, Priscilla K.
    CANCER, 2019, 125 (17) : 2910 - 2914
  • [2] Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation
    Yilamujiang Ainiwan
    Haomin Li
    Yongjia Zheng
    Songtao Wei
    Junxiang Peng
    Jing Nie
    Chaofu Mao
    Kunxiang Chen
    Siyuan Chen
    Ningyuan Liu
    Can Li
    Yan Chen
    Shanqiang Qu
    Yunji Wang
    Mingfeng Zhou
    Jian Mao
    Fen Mei
    Jingting Chen
    Qiancheng Song
    Songtao Qi
    Jun Pan
    Acta Neuropathologica Communications, 13 (1)
  • [3] Collagen Increases Proliferation and Drug Resistance of Papillary Thyroid Cancer Cells Harboring BRAFV600E Mutations.
    MacDonald, L. J.
    Sharabura, A.
    Jenkins, J.
    Anderson, B.
    LeBoeuf, B.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [4] The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
    Yangsen Li
    Yuanyuan Wang
    Liwen Li
    Xinguang Qiu
    Scientific Reports, 12
  • [5] The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
    Li, Yangsen
    Wang, Yuanyuan
    Li, Liwen
    Qiu, Xinguang
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma
    Wei, Xiaojing
    Wang, Xiaodong
    Xiong, Jie
    Li, Chen
    Liao, Yixuan
    Zhu, Yongjun
    Mao, Jingxin
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [7] Is There an Alternative Treatment Option for Patients with Advanced Papillary Thyroid Cancer (PTC) Harboring the BRAFV600E Mutation?
    Dadu, Ramona
    Shah, Komal
    Bassett, Roland L., Jr.
    Busaidy, Naifa L.
    Waguespack, Steven G.
    Sherman, Steven I.
    Habra, Mouhammed Amir
    Jimenez, Camilo
    Hu, Mimi I-Nan
    Ying, Anita K.
    Cabanillas, Maria E.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [8] The relevance of the BRAFV600E mutation in the treatment of the Papillary Thyroid Carcinoma
    Ajuria, O.
    Navarro Martinez, T.
    Lorente Castro, B.
    Castro Beiras, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S652 - S652
  • [9] BRAFV600E and Recurrence in Papillary Carcinoma Thyroid
    Kumari, N.
    George, N.
    Shukla, P.
    Vishwakarma, R.
    Agarwal, A.
    Krishnani, N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 827 - 827
  • [10] Targeted Therapy for BRAFV600E Malignant Astrocytoma
    Nicolaides, Theodore P.
    Li, Huifang
    Solomon, David A.
    Hariono, Sujatmi
    Hashizume, Rintaro
    Barkovich, Krister
    Baker, Suzanne J.
    Paugh, Barbara S.
    Jones, Chris
    Forshew, Tim
    Hindley, Guy F.
    Hodgson, J. Graeme
    Kim, Jung-Sik
    Rowitch, David H.
    Weiss, William A.
    Waldman, Todd A.
    James, C. David
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7595 - 7604
12345